BeiGene

+$6.81 (+3.76%) As of 1:54 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.

About BGNE

BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V.

CEO
John V. Oyler
Employees
8,200
Headquarters
Cambridge, Massachusetts
Founded
2010

BGNE Key Statistics

Market cap
22.88B
Price-Earnings ratio
—
Dividend yield
—
Average volume
339.15K
High today
$189.01
Low today
$181.26
Open price
$181.27
Volume
26.28K
52 Week high
$426.56
52 Week low
$118.18

BGNE News

MarketWatch22h

BeiGene Shares Drop 12% After Deal to License InnoRNA Technology - MarketWatch

By Chris Wack BeiGene Ltd. shares fell 12% to $171.90 after the company said it entered into a worldwide strategic collaboration with InnoRNA to use its techno

BGNE Earnings

-$6.16
-$3.88
-$1.59
$0.69
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure